Gender-affirming treatment of transgender people requires a multidisciplinary approach in
which endocrinologists play a crucial role. The aim of this paper is to review recent data on …

Meningiomas are common intracranial tumors with a female predominance. Their etiology is
still poorly documented. The role of sexual hormones has long been evoked, and data have …

Objective To assess the risk of meningioma associated with use of high dose cyproterone
acetate, a progestogen indicated for clinical hyperandrogenism. Design Observational …

Transgender men and women represent about 0.6-1.1%% of the general population.
Gender affirming hormone therapy (GAHT) helps ameliorate gender dysphoria and promote …

Background The study the characteristics of surgical meningiomas in female patients who
took CPA and to compare this population to a non-CPA control group. Materials and …

Background The relationship between meningiomas and exogenous sex hormones is well
known, but cyproterone acetate (CA), a progesterone agonist, seems to have a stronger …

Background: The aetiology of meningiomas is largely unknown although hormones have
been suggested to play a role. Methods: A cohort study was performed to evaluate hormone …

Background Cyproterone acetate (CA) is an antiandrogenic progestin commonly used in
adult transwomen to suppress endogenous androgens, often in combination with estrogens …

Purpose To report the results of systematic meningioma screening program implemented by
French authorities in patients exposed to progestin therapies (cyproterone (CPA) …

The administration of cyproterone acetate (CPA) and estradiol is a common regimen used
by male-to-female transsexuals (transwoman) to adjust their body to their gender identity …